Evaluation of All'InCath in Peripheral Vasculature Percutaneous Transluminal Angioplasty.

Phase

TERMINATED

Status

Enrollment

INDUSTRY

Sponsor class

Stopped As part of the new regulatory requirements in Europe and in accordance with the MDR regulation set to take effect on January 1, 2025, NexStep Medical is compelled to prematurely terminate its ongoing clinical study.

Conditions

Vascular Diseases

Interventions

DEVICE: All'InCath CBC 035M Balloon Dilatation Catheter

Sponsor

NexStep Medical